NASDAQ : AMPH
Amphastar Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 27.72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Amphastar Pharmaceuticals, Inc. (AMPH) reported revenue of 730.02M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 730.02M | 719.89M | 712.81M | 593.24M | 498.99M | 437.77M |
| Other Revenue | 19.15M | 51.16M | ||||
| Revenue | 730.02M | 719.89M | 731.97M | 644.39M | 498.99M | 437.77M |
| Cost of Revenue | 381.91M | 363.83M | 358.11M | 293.27M | 250.13M | 238.03M |
| Gross Profit | 348.11M | 356.06M | 373.86M | 351.12M | 248.86M | 199.74M |
| Selling, General & Admin | 116.15M | 106.71M | 94.52M | 80.39M | 66.59M | 67.12M |
| Research & Development | 94.57M | 85.84M | 73.91M | 73.74M | 74.77M | 60.93M |
| Operating Expenses | 210.72M | 192.55M | 168.44M | 154.13M | 141.36M | 128.05M |
| Operating Income | 137.38M | 163.50M | 205.42M | 196.99M | 107.50M | 71.69M |
| Interest Expense | -21.73M | -29.78M | -35.34M | -33.06M | -1.85M | -885.00K |
| Interest & Investment Income | 9.36M | 8.68M | 10.61M | 5.46M | 1.32M | 601.00K |
| Earnings From Equity Investments | -573.00K | -1.98M | -1.18M | -208.00K | ||
| Other Non Operating Income (Expenses) | 5.01M | 4.32M | 9.08M | 1.97M | 9.07M | 13.54M |
| EBT Excluding Unusual Items | 125.12M | 146.72M | 189.19M | 169.38M | 114.86M | 84.73M |
| Legal Settlements | -23.10M | -23.10M | 1.00M | |||
| Other Unusual Items | -1.80M | |||||
| Pretax Income | 102.02M | 123.62M | 189.19M | 169.38M | 114.86M | 83.93M |
| Income Tax Expense | 23.48M | 25.53M | 29.67M | 31.83M | 23.48M | 20.63M |
| Earnings From Continuing Operations | 78.55M | 98.09M | 159.52M | 137.54M | 91.39M | 63.30M |
| Minority Interest in Earnings | -1.19M | |||||
| Net Income | 78.55M | 98.09M | 159.52M | 137.54M | 91.39M | 62.12M |
| Net Income to Common | 78.55M | 98.09M | 159.52M | 137.54M | 91.39M | 62.12M |
| Shares Outstanding (Basic) | 45.34M | 46.74M | 48.43M | 48.27M | 48.55M | 47.78M |
| Shares Outstanding (Diluted) | 46.38M | 48.22M | 52.06M | 53.00M | 52.43M | 49.78M |
| EPS (Basic) | 1.73 | 2.10 | 3.29 | 2.85 | 1.88 | 1.30 |
| EPS (Diluted) | 1.69 | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 |
| Free Cash Flow | 152.89M | 121.23M | 172.34M | 145.34M | 65.15M | 70.54M |
| Free Cash Flow Per Share | 3.30 | 2.51 | 3.31 | 2.74 | 1.24 | 1.42 |
| Gross Margin | 47.69% | 49.46% | 51.08% | 54.49% | 49.87% | 45.63% |
| Operating Margin | 18.82% | 22.71% | 28.06% | 30.57% | 21.54% | 16.38% |
| Profit Margin | 10.76% | 13.63% | 21.79% | 21.34% | 18.31% | 14.19% |
| Free Cash Flow Margin | 20.94% | 16.84% | 23.54% | 22.55% | 13.06% | 16.11% |
| EBITDA | 194.51M | 220.20M | 258.39M | 235.02M | 132.27M | 94.95M |
| EBITDA Margin | 26.65% | 30.59% | 35.30% | 36.47% | 26.51% | 21.69% |
| D&A For EBITDA | 57.13M | 56.70M | 52.97M | 38.03M | 24.77M | 23.27M |
| EBIT | 137.38M | 163.50M | 205.42M | 196.99M | 107.50M | 71.69M |
| EBIT Margin | 18.82% | 22.71% | 28.06% | 30.57% | 21.54% | 16.38% |
| Effective Tax Rate | 23.01% | 20.65% | 15.68% | 18.79% | 20.44% | 24.58% |
| Revenue as Reported | 719.89M | 719.89M | 731.97M | 644.39M | 498.99M | 437.77M |
| Advertising Expenses | 10.20M | 10.50M | 10.40M | 8.70M | 8.10M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 223.61M | 170.18M | 151.61M | 144.30M | 156.10M | 126.35M |
| Short-Term Investments | 66.51M | 112.64M | 70.04M | 112.51M | 19.66M | 10.32M |
| Cash & Short-Term Investments | 290.12M | 282.81M | 221.65M | 256.81M | 175.76M | 136.67M |
| Accounts Receivable | 144.86M | 143.56M | 136.29M | 114.94M | 88.80M | 78.80M |
| Other Receivables | 2.63M | 17.17M | 1.75M | 526.00K | 171.00K | 126.00K |
| Receivables | 147.49M | 160.73M | 138.04M | 115.47M | 88.97M | 78.93M |
| Inventory | 179.91M | 176.89M | 153.74M | 105.83M | 103.58M | 92.81M |
| Prepaid Expenses | 11.00M | 13.15M | 18.21M | 9.06M | 7.56M | 7.27M |
| Restricted Cash | 235.00K | 235.00K | 235.00K | 235.00K | 235.00K | 235.00K |
| Other Current Assets | 2.20M | 2.20M | 2.20M | 2.20M | 2.20M | 2.20M |
| Total Current Assets | 630.95M | 636.02M | 534.07M | 489.60M | 378.32M | 318.12M |
| Property, Plant & Equipment | 389.13M | 353.72M | 344.63M | 315.64M | 264.57M | 271.49M |
| Long-Term Investments | 11.00M | 15.21M | 2.41M | 3.98M | ||
| Goodwill | 3.31M | 3.40M | 3.05M | 3.22M | 3.13M | 3.31M |
| Other Intangible Assets | 644.52M | 562.56M | 587.61M | 610.08M | 34.17M | 35.56M |
| Long-Term Deferred Tax Assets | 42.46M | 42.46M | 71.12M | 53.25M | 38.53M | 22.40M |
| Other Long-Term Assets | 33.39M | 31.14M | 25.99M | 25.91M | 20.86M | 16.66M |
| Total Assets | 1.74B | 1.63B | 1.58B | 1.51B | 741.99M | 671.53M |
| Accounts Payable | 28.93M | 32.59M | 30.51M | 25.44M | 20.50M | 22.21M |
| Accrued Expenses | 201.70M | 96.76M | 103.10M | 54.75M | 46.19M | 44.17M |
| Current Portion of Long-Term Debt | 2.49M | 1.47M | 234.00K | 436.00K | 3.05M | 2.20M |
| Current Portion of Leases | 8.80M | 8.10M | 6.80M | 3.91M | 3.00M | 2.98M |
| Current Income Taxes Payable | 546.00K | 239.00K | 9.66M | 1.61M | 4.57M | 9.08M |
| Other Current Liabilities | 20.74M | 19.00M | 23.44M | 139.27M | 17.55M | 23.16M |
| Total Current Liabilities | 263.20M | 158.16M | 173.76M | 225.41M | 94.86M | 103.81M |
| Long-Term Debt | 609.38M | 608.66M | 601.20M | 588.96M | 72.84M | 74.38M |
| Long-Term Leases | 67.66M | 37.77M | 42.31M | 30.34M | 23.69M | 25.10M |
| Pension & Post-Retirement Benefits | 2.60M | 2.60M | 2.60M | 2.60M | ||
| Long-Term Deferred Tax Liabilities | 144.00K | 534.00K | ||||
| Other Long-Term Liabilities | 32.77M | 33.30M | 25.30M | 26.18M | 21.79M | 22.18M |
| Total Liabilities | 975.61M | 840.49M | 845.17M | 873.49M | 213.33M | 226.01M |
| Common Stock | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Additional Paid-In Capital | 553.00M | 535.38M | 505.40M | 486.06M | 455.08M | 422.42M |
| Retained Earnings | 703.65M | 666.88M | 568.79M | 409.27M | 271.72M | 180.34M |
| Treasury Stock | -482.60M | -408.15M | -332.71M | -247.43M | -189.52M | -150.48M |
| Comprehensive Income & Other | -5.90M | -5.31M | -9.18M | -8.48M | -8.62M | -6.76M |
| Total Common Equity | 768.16M | 788.80M | 732.30M | 639.42M | 528.66M | 445.52M |
| Shareholders' Equity | 768.16M | 788.80M | 732.30M | 639.42M | 528.66M | 445.52M |
| Total Liabilities & Equity | 1.74B | 1.63B | 1.58B | 1.51B | 741.99M | 671.53M |
| Total Debt | 688.32M | 656.00M | 650.55M | 623.64M | 102.58M | 104.66M |
| Net Cash (Debt) | -398.20M | -373.19M | -428.90M | -366.84M | 73.18M | 32.01M |
| Net Cash Per Share | -8.59 | -7.74 | -8.24 | -6.92 | 1.40 | 0.64 |
| Filing Date Shares Outstanding | 42.54M | 45.37M | 47.65M | 48.10M | 47.90M | 48.15M |
| Total Common Shares Outstanding | 42.53M | 45.65M | 47.62M | 48.07M | 48.11M | 47.71M |
| Working Capital | 367.75M | 477.86M | 360.31M | 264.19M | 283.46M | 214.31M |
| Book Value Per Share | 18.06 | 17.28 | 15.38 | 13.30 | 10.99 | 9.34 |
| Tangible Book Value | 120.32M | 222.84M | 141.64M | 26.13M | 491.36M | 406.65M |
| Tangible Book Value Per Share | 2.83 | 4.88 | 2.97 | 0.54 | 10.21 | 8.52 |
| Land | 7.52M | 7.55M | 7.42M | 7.48M | 7.45M | 7.62M |
| Buildings | 196.36M | 196.68M | 169.43M | 168.77M | 130.73M | 130.58M |
| Machinery | 352.26M | 342.10M | 313.38M | 291.43M | 237.74M | 235.26M |
| Construction In Progress | 34.77M | 24.41M | 36.69M | 18.68M | 50.84M | 41.19M |
| Leasehold Improvements | 46.37M | 46.10M | 42.01M | 41.69M | 31.54M | 29.22M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 78.55M | 98.09M | 159.52M | 137.54M | 91.39M | 62.12M |
| Depreciation & Amortization | 64.71M | 63.20M | 57.20M | 41.78M | 28.27M | 26.53M |
| Other Amortization | 3.39M | 3.35M | 6.03M | 11.40M | 466.00K | 219.00K |
| Loss (Gain) From Sale of Assets | 20.00K | 39.00K | 9.00K | 475.00K | 141.00K | -13.24M |
| Asset Writedown & Restructuring Costs | 2.70M | |||||
| Loss (Gain) From Sale of Investments | -539.00K | 2.49M | -2.79M | 5.33M | -2.20M | 27.00K |
| Loss (Gain) on Equity Investments | 573.00K | 1.98M | 1.18M | 208.00K | ||
| Stock-Based Compensation | 28.87M | 27.28M | 24.37M | 20.24M | 17.86M | 18.69M |
| Other Operating Activities | 27.63M | 27.63M | -16.98M | -13.74M | -15.75M | 5.39M |
| Change in Accounts Receivable | -12.13M | -6.37M | -21.67M | -26.09M | -10.13M | -14.92M |
| Change in Inventory | 11.24M | -21.06M | -48.80M | -1.72M | -11.75M | 1.26M |
| Change in Accounts Payable | -5.74M | -4.56M | 63.56M | 13.24M | -736.00K | 3.63M |
| Change in Income Taxes | -1.53M | -24.84M | 6.83M | -3.32M | -4.55M | 8.35M |
| Change in Other Net Operating Assets | -9.85M | -9.14M | -14.48M | -6.32M | -5.01M | -271.00K |
| Operating Cash Flow | 184.61M | 156.12M | 213.39M | 183.50M | 89.18M | 97.99M |
| Capital Expenditures | -31.72M | -34.88M | -41.04M | -38.17M | -24.03M | -27.46M |
| Sale of Property, Plant & Equipment | 421.00K | |||||
| Cash Acquisitions | -129.00M | -506.41M | ||||
| Sale (Purchase) of Intangibles | -2.25M | |||||
| Investment in Securities | -16.51M | -28.84M | 49.23M | -105.93M | -7.79M | 1.40M |
| Other Investing Activities | -3.82M | -4.36M | -4.12M | 1.39M | -1.37M | -2.61M |
| Investing Cash Flow | -52.05M | -70.33M | -124.93M | -649.12M | -32.78M | -28.67M |
| Long-Term Debt Issued | 6.22M | 18.43M | 845.00M | 70.00M | ||
| Long-Term Debt Repaid | -223.00K | -8.26M | -318.66M | -1.78M | -37.90M | |
| Net Debt Issued (Repaid) | -257.00K | 5.99M | 10.17M | 526.34M | -1.78M | 32.10M |
| Issuance of Common Stock | 3.88M | 2.85M | 10.97M | 15.66M | 15.93M | |
| Repurchase of Common Stock | -100.07M | -75.59M | -90.31M | -58.14M | -39.91M | -28.87M |
| Other Financing Activities | -12.00K | -687.00K | -816.00K | -25.08M | -407.00K | -56.17M |
| Financing Cash Flow | -96.46M | -67.42M | -80.95M | 454.09M | -26.44M | -37.02M |
| Foreign Exchange Rate Adjustments | -172.00K | 210.00K | -190.00K | -282.00K | -220.00K | -223.00K |
| Net Cash Flow | 35.92M | 18.57M | 7.31M | -11.80M | 29.75M | 32.08M |
| Free Cash Flow | 152.89M | 121.23M | 172.34M | 145.34M | 65.15M | 70.54M |
| Free Cash Flow Margin | 20.94% | 16.84% | 23.54% | 22.55% | 13.06% | 16.11% |
| Free Cash Flow Per Share | 3.30 | 2.51 | 3.31 | 2.74 | 1.24 | 1.42 |
| Levered Free Cash Flow | 230.10M | 81.37M | 18.89M | 239.72M | 57.67M | 56.90M |
| Unlevered Free Cash Flow | 240.29M | 96.62M | 34.94M | 248.98M | 58.36M | 57.23M |
| Cash Interest Paid | 22.95M | 23.22M | 26.81M | 17.57M | 3.02M | 2.11M |
| Cash Income Tax Paid | 22.71M | 40.10M | 49.00M | 44.44M | 8.10M | |
| Change in Working Capital | -18.01M | -65.97M | -14.55M | -24.21M | -32.18M | -1.95M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.18B | 1.23B | 1.79B | 2.96B | 1.35B | 1.11B |
| Enterprise Value | 1.58B | 1.61B | 2.16B | 3.34B | 1.27B | 1.11B |
| Last Close Price | 27.72 | 26.78 | 37.13 | 61.85 | 28.02 | 23.29 |
| PE Ratio | 16.43 | 12.54 | 11.19 | 21.54 | 14.82 | 17.94 |
| Forward PE | 8.74 | 7.78 | 9.42 | 20.77 | 16.29 | 16.96 |
| PS Ratio | 1.62 | 1.71 | 2.44 | 4.60 | 2.71 | 2.55 |
| PB Ratio | 1.53 | 1.56 | 2.44 | 4.63 | 2.56 | 2.50 |
| P/TBV Ratio | 9.80 | 5.52 | 12.60 | 113.42 | 2.76 | 2.74 |
| P/FCF Ratio | 7.71 | 10.15 | 10.36 | 20.39 | 20.79 | 15.80 |
| P/OCF Ratio | 6.39 | 7.88 | 8.37 | 16.15 | 15.19 | 11.37 |
| PEG Ratio | 7.01 | 0.99 | 0.92 | 0.86 | 0.89 | |
| EV/Sales Ratio | 2.16 | 2.24 | 2.96 | 5.18 | 2.55 | 2.53 |
| EV/EBITDA Ratio | 8.11 | 7.32 | 8.38 | 14.19 | 9.63 | 11.65 |
| EV/EBIT Ratio | 11.48 | 9.85 | 10.54 | 16.93 | 11.85 | 15.43 |
| EV/FCF Ratio | 10.32 | 13.29 | 12.56 | 22.95 | 19.55 | 15.68 |
| Debt / Equity Ratio | 0.90 | 0.83 | 0.89 | 0.97 | 0.19 | 0.23 |
| Debt / EBITDA Ratio | 3.33 | 2.85 | 2.46 | 2.59 | 0.75 | 1.05 |
| Debt / FCF Ratio | 4.50 | 5.41 | 3.77 | 4.29 | 1.57 | 1.48 |
| Net Debt / Equity Ratio | 0.52 | 0.47 | 0.59 | 0.57 | -0.14 | -0.07 |
| Net Debt / EBITDA Ratio | 2.05 | 1.70 | 1.66 | 1.56 | -0.55 | -0.34 |
| Net Debt / FCF Ratio | 2.60 | 3.08 | 2.49 | 2.52 | -1.12 | -0.45 |
| Asset Turnover | 0.43 | 0.45 | 0.47 | 0.57 | 0.71 | 0.67 |
| Inventory Turnover | 2.06 | 2.20 | 2.76 | 2.80 | 2.55 | 2.51 |
| Quick Ratio | 1.66 | 2.80 | 2.07 | 1.65 | 2.79 | 2.08 |
| Current Ratio | 2.40 | 4.02 | 3.07 | 2.17 | 3.99 | 3.06 |
| Return on Equity (ROE) | 10.30% | 12.90% | 23.26% | 23.55% | 18.76% | 14.16% |
| Return on Assets (ROA) | 5.11% | 6.37% | 8.31% | 10.92% | 9.51% | 6.88% |
| Return on Invested Capital (ROIC) | 9.06% | 11.17% | 15.98% | 21.89% | 19.68% | 13.12% |
| Return on Capital Employed (ROCE) | 9.30% | 11.10% | 14.60% | 15.30% | 16.60% | 12.60% |
| Earnings Yield | 6.09% | 7.97% | 8.94% | 4.64% | 6.75% | 5.57% |
| FCF Yield | 12.97% | 9.85% | 9.65% | 4.91% | 4.81% | 6.33% |
| Buyback Yield / Dilution | 7.79% | 7.38% | 1.78% | -1.09% | -5.31% | -1.34% |